Veröffentlichungsdatum: 29 September 2021
Projektträger – zwischengeschaltetes Finanzinstitut
BANQUE FEDERATIVE DU CREDIT MUTUELOrt
Beschreibung
The operation is a EUR 250 million multiple beneficiary intermediated loan which aims at facilitating access to long-term finance for projects carried out by professionals/small and medium-sized enterprises (SMEs) active in the healthcare and pharmaceutical sectors in France with a 5% window dedicated to regions where access to medical experts is sub-optimal/underserved.
Additionality and Impact
The proposed operation will support investments carried out by SMEs operating in the healthcare sector in France.
Thanks to EIB intervention, competition between FIs active on this market in France will be enhanced whilst funding conditions for healthcare professionals will be improved (pricing decrease is contractually stated) insuring a better access to finance to Final Beneficiaries.
The propose operation is also expected to improve citizen's access to medical professional across the territory by supporting the launch of new business in the healthcare sector, especially in underserved regions.
Ziele
Financing of small/medium projects carried out by professionals and SMEs active in the healthcare and pharmaceutical sectors in France.
Sektor(en)
- Durchleitungsdarlehen - Durchleitungsdarlehen
Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)
EUR 250 million
Gesamtkosten (voraussichtlicher Betrag)
not applicable
Umweltaspekte
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Auftragsvergabe
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Projektstatus
Unterzeichnet - 16/12/2021
Haftungsausschluss
Bis Finanzierungen vom Verwaltungsrat genehmigt und anschließend unterzeichnet werden, befinden sich die Projekte in der Prüfungs- oder Verhandlungsphase. Die Angaben auf dieser Seite sind daher unverbindlich.
Sie dienen lediglich der Transparenz und stellen nicht die offizielle EIB-Politik dar (vgl. auch die erklärenden Anmerkungen).